Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Core EBITDA Growth(%) -64.13-23.46-24.787.6324.25

What is the latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BALAXI PHARMACEUTICALS is -64.13 based on Mar2026 Consolidated results.
Year Core EBITDA Growth
Mar2026-64.13
Mar2025-23.46
Mar2024-24.78
Mar20237.63
Mar202224.25

How is Core EBITDA Growth of BALAXI PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2026 -64.13
Negative
Mar2025 -23.46
Negative
Mar2024 -24.78
Negative
Mar2023 7.63
-68.54
Mar2022 24.25 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹125.9 Cr -3.8% -6.8% -53.3% Stock Analytics
ADANI ENTERPRISES ₹403,409.0 Cr -0.8% -1.6% 32.3% Stock Analytics
AEGIS LOGISTICS ₹47,111.2 Cr -1.9% -0.5% 104.2% Stock Analytics
PREMIER ENERGIES ₹46,666.2 Cr 1.3% 0.9% 5.5% Stock Analytics
ADITYA INFOTECH ₹40,428.0 Cr 2.3% -3.3% 218.6% Stock Analytics
REDINGTON ₹28,538.7 Cr 11.9% 40.9% 46% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-3.8%

-6.8%

-53.3%

SENSEX

-0.5%

1.3%

-4%


You may also like the below Video Courses